Rashmi K Murthy Selected Research

Angiozyme

9/2012

An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rashmi K Murthy Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2012
12	Neoplasms (Cancer) 01/2022 - 12/2009
6	Triple Negative Breast Neoplasms 01/2022 - 04/2017
4	Pathologic Complete Response 01/2022 - 12/2018
4	Disease Progression 01/2020 - 09/2012
2	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2009
2	Brain Neoplasms (Brain Tumor) 10/2020 - 01/2020
2	Diarrhea 01/2020 - 07/2017
1	Residual Neoplasm 11/2021
1	Nausea 01/2020
1	Cardiotoxicity 01/2020
1	Inflammatory Breast Neoplasms 01/2020
1	Fatigue 01/2020
1	Vomiting 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Hypokalemia 07/2017
1	Anemia 07/2017
1	Exanthema (Rash) 07/2017
1	Bone Resorption 12/2009
1	Multiple Myeloma 12/2009
1	Bone Diseases (Bone Disease) 12/2009
1	Osteolysis 12/2009

Drug/Important Bio-Agent (IBA)

11	Trastuzumab (Herceptin)FDA Link 01/2021 - 07/2014
5	Hormones (Hormone)IBA 01/2021 - 12/2018
4	human ERBB2 proteinIBA 01/2021 - 07/2014
3	Capecitabine (Xeloda)FDA Link 10/2020 - 07/2019
3	tucatinibIBA 10/2020 - 07/2017
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2019
3	pertuzumabIBA 01/2020 - 12/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2020
2	HER2 peptide (369-377)IBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 07/2019
2	trastuzumab deruxtecanIBA 10/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2020 - 07/2017
2	Letrozole (Femara)FDA LinkGeneric 07/2019 - 12/2018
2	Lapatinib (GW572016)FDA Link 07/2019 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 12/2018
1	VaccinesIBA 01/2021
1	talazoparibIBA 10/2020
1	Estrogen ReceptorsIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2020
1	thiamine triphosphorate (TTP)IBA 07/2019
1	telomerase RNA (bTR)IBA 07/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	entinostat (MS 275)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 12/2018
1	Estrogens (Estrogen)FDA Link 12/2018
1	Gemcitabine FDA Link 01/2018
1	tipifarnib (R115777)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 04/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2017
1	liposomal doxorubicin (Doxil)FDA Link 04/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	AngiozymeIBA 09/2012
1	OsteoprotegerinIBA 12/2009
1	RANK LigandIBA 12/2009

Therapy/Procedure

11	Therapeutics 01/2021 - 12/2009
6	Drug Therapy (Chemotherapy) 11/2021 - 09/2012
3	Neoadjuvant Therapy 01/2022 - 01/2020
1	Investigational Therapies (Experimental Therapy) 11/2021
1	Biological Therapy 01/2021